Single-Dose Antibiotic Prophylaxis in Core Prostate Biopsy: Impact of Timing and Identification of Risk Factors
Authors:
- Sandra LindstedtSandra Lindstedt
- Magnus GrabeMGMagnus Grabe
- 1 October 2006
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 50 (4) , 832-837
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening programUrology, 2002
- SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDYJournal of Urology, 2001
- BACTEREMIA AND BACTERIURIA AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSYJournal of Urology, 2000
- Antibiotic Prophylaxis for Transrectal Biopsy of the Prostate: A Prospective Randomized Study of the Prophylactic Use of Single Dose Oral Fluoroquinolone Versus Trimethoprim-SulfamethoxazoleInternational Urology and Nephrology, 1999
- Patients’ tolerance of transrectal ultrasound‐guided prostatic biopsy: an audit of 104 casesBJU International, 1999
- Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsyUrology, 1998
- Morbidity of ultrasound‐guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 casesBritish Journal of Urology, 1997
- Prevention of Urinary Tract Infection and Sepsis Following Transrectal Prostatic BiopsyJournal of Urology, 1982
- Transrectal biopsy of the prostate and bacteraemiaBritish Journal of Surgery, 1980